Encyclopedia of Immunology Research

944 Pages·2012·11.038 MB·English

by  Meredith E. Daniels

IMMUNOLOGY AND IMMUNE SYSTEM DISORDERS

E
NCYCLOPEDIA
I R
OF MMUNOLOGY ESEARCH

No part of this digital document may be reproduced, stored in a retrieval system or transmitted in any form or
by any means. The publisher has taken reasonable care in the preparation of this digital document, but makes no
expressed or implied warranty of any kind and assumes no responsibility for any errors or omissions. No
liability is assumed for incidental or consequential damages in connection with or arising out of information
contained herein. This digital document is sold with the clear understanding that the publisher is not engaged in
rendering legal, medical or any other professional services.
I I
MMUNOLOGY AND MMUNE
S D
YSTEM ISORDERS

Additional books in this series can be found on Nova’s website
under the Series tab.

Additional E-books in this series can be found on Nova’s website
under the E-books tab.
IMMUNOLOGY AND IMMUNE SYSTEM DISORDERS

E
NCYCLOPEDIA
I R
OF MMUNOLOGY ESEARCH

MEREDITH E. DANIELS
EDITOR

Nova Science Publishers, Inc.
New York
Copyright © 2012 by Nova Science Publishers, Inc.

All rights reserved. No part of this book may be reproduced, stored in a retrieval system or
transmitted in any form or by any means: electronic, electrostatic, magnetic, tape, mechanical
photocopying, recording or otherwise without the written permission of the Publisher.

For permission to use material from this book please contact us:
Telephone [phone]; Fax [phone]
Web Site: http://www.novapublishers.com

NOTICE TO THE READER

The Publisher has taken reasonable care in the preparation of this book, but makes no expressed or
implied warranty of any kind and assumes no responsibility for any errors or omissions. No
liability is assumed for incidental or consequential damages in connection with or arising out of
information contained in this book. The Publisher shall not be liable for any special,
consequential, or exemplary damages resulting, in whole or in part, from the readers’ use of, or
reliance upon, this material. Any parts of this book based on government reports are so indicated
and copyright is claimed for those parts to the extent applicable to compilations of such works.

Independent verification should be sought for any data, advice or recommendations contained in
this book. In addition, no responsibility is assumed by the publisher for any injury and/or damage
to persons or property arising from any methods, products, instructions, ideas or otherwise
contained in this publication.

This publication is designed to provide accurate and authoritative information with regard to the
subject matter covered herein. It is sold with the clear understanding that the Publisher is not
engaged in rendering legal or any other professional services. If legal or any other expert
assistance is required, the services of a competent person should be sought. FROM A
DECLARATION OF PARTICIPANTS JOINTLY ADOPTED BY A COMMITTEE OF THE
AMERICAN BAR ASSOCIATION AND A COMMITTEE OF PUBLISHERS.

Additional color graphics may be available in the e-book version of this book.

Library of Congress Cataloging-in-Publication Data

ISBN: (cid:28)(cid:26)(cid:27)(cid:16)(cid:20)(cid:16)(cid:25)(cid:20)(cid:22)(cid:21)(cid:23)(cid:16)(cid:27)(cid:27)(cid:22)(cid:16)(cid:25) (eBook)

The Library of Congress has cataloged the original edition of this title under LCCN 2008050550

Published by Nova Science Publishers, Inc.† New York
Contents

Preface ix
Volume 1
Chapter 1 Adjuvants in Cancer Vaccination 1
Ralf Kircheis and Andreas Nechansky
Chapter 2 TLR Agonists as Immune Adjuvants 45
Yanal Murad and Bara Sarraj
Chapter 3 Modulating Immune Response with CpG-Oligodeoxynucleotide
through the Skin 69
Joe Inoue and Yukihiko Aramaki
Chapter 4 Immunopotentiating Reconstituted Influenza Virosomes
as Safe and Potent Antigen-Delivery System for Synthetic
Peptides in Vaccine Development 83
Claudia A. Daubenberger, Gerd Pluschke,
Rinaldo Zurbriggen and Nicole Westerfeld
Chapter 5 Vaccine Adjuvants: Priorities and Challenges 93
Ali M. Harandi and Ole F. Olesen
Chapter 6 The Involvement of Interleukin-6 in the Augmentation of Immune
Response by Immunologic Adjuvants 101
Masahiko Mihara and Hiroto Yoshida
Chapter 7 Is there a Future for Costimulation Blockade as a Regulatory
T-Cell Inducing Therapy? 109
Krista G. Haanstra, Bert A. ’t Hart, Frans H. J. Claas
and Margreet Jonker
Chapter 8 Strategies for T Cell Depletion to Prevent Graft versus Host Disease 153
Liang-Piu Koh and David A. Rizzieri
vi Contents
Chapter 9 Leucocyte Intracellular Cytokines in Lung Transplant Patients-
A More Physiological Indicator of Immunosuppression
than Plasma Drug Levels 197
Greg Hodge, Sandra Hodge, Paul Reynolds,
Daniel Chambers and Mark Holmes
Chapter 10 Indications and Management of m-TOR Inhibitors
after Liver Transplantation 223
Itxarone Bilbao, Gonzalo Sapisochin, Cristina Dopazo,
Jose Luis Lazaro, Leonor Pou, Luis Castells, Mireia Caralt,
Amaia Gantxegi and Ramon Charco
Chapter 11 Evolution of Immunosuppression in Liver Transplantation 241
Olga N. Tucker and Nigel Heaton
Chapter 12 The Role of Pharmacogenomics in Tailoring Immunosuppressive
Therapy for Liver Transplant Recipients 263
Nyingi Kemmer, Pankaj B. Desai and Guy W. Neff
Chapter 13 Immunosuppression Caused by Photochemo- and Photodynamic
Therapy: Focus on Photosensitizer Photoproducts 277
A. A. Kyagova, M. V. Malakhov and A. Ya. Potapenko
Chapter 14 Sunlight Induced Immunosuppression: A Role for Inflammatory
Mediators in the Induction of Suppressor Cells 295
Scott N. Byrne and Gary M. Halliday
Volume 2
Chapter 15 Immunosuppressive Therapy in Adult to Adult
Living-Related Liver Transplantation 319
S. Gruttadauria,, J. Viganò, J. W. Marsh,
A. Marcos and B. Gridelli
Chapter 16 High-Dose Immunosuppression with Autologous
Stem Cell Transplantation in Severe Refractory
Systemic Lupus Erythematosus 333
Igor A. Lisukov, Vera V. Sergeevicheva, Svetlana A. Sizikova,
Alexander D. Kulagin, Irina V. Kruchkova, Andrey V. Gilevich,
Alexey E. Sizikov, Ludmila P. Konenkova, Elena R. Chernykh,
Olga Y. Leplina and Vladimir A. Kozlov
Chapter 17 Experimental Approaches for Transplantation of Islets in the
Absence of Immunosuppression 349
Bart J. de Haan, Marijke M. Faas, Albert F. Hamel
and Paul de Vos
Chapter 18 Oxidative Stress Peripheral Markers in Graves’ Ophthalmopathy
Patients during Combined Immunosuppression 381
Janusz Bednarek, Henryk Wysocki and Jerzy Sowiński
Contents vii
Chapter 19 The Phenomenon of Antibiotic Resistance
in an Evolutionary Perspective 393
Roberto Manfredi
Chapter 20 Antibiotic Resistance and Probiotics:
Roles, Mechanisms and Evidence 397
Min-Tze Liong, Siok-Koon Yeo, Chiu-Yin Kuan,
Wai-Yee Fung and Joo-Ann Ewe
Chapter 21 When Good Bugs Fight Bad – Designing Probiotics
to Control Antibiotic Resistant “Superbugs” 431
Roy D. Sleator
Chapter 22 Modification of the Bacterial Phenotype as an Approach
to Counter the Emergence of Multidrug-Resistant Pathogens 435
Peter W. Taylor, Patricia Bernal and Andrea Zelmer
Chapter 23 Performance to Antibiotics in Staphylococcus Aureus,
Streptococcus Agalactiae and Enterococcus spp 469
Antonio Sorlózano, José Gutiérrez, Eva Román, Juan de Dios Luna,
Juan Román, Estrella Martín, José Liébana, José Luis García,
Samuel Bernal and Pilar Morales
Chapter 24 Microbiological and Pharmacological Principles
of Recent Antibiotic Therapy 485
Cristina Carrasco, Antonio Sorlózano, José Cabeza,
Gonzalo Piédrola and José Gutiérrez
Chapter 25 Bacteriophage Therapies and Enzybiotics:
Novel Solutions to Antibiotic Resistance 573
Noémie Manuelle Dorval Courchesne,
Albert Parisien and Christopher Q. Lan
Volume 3
Chapter 26 Application of Computational Methods to Study
Antibiotic Resistance Mechanisms: Fluoroquinolone
Resistance as a Case Study 601
Sergio Madurga, Jordi Vila and Ernest Giralt
Chapter 27 Energetics of MDR Microbial Cells 631
Waché Yves
Chapter 28 Low Impact of OmpC and OmpF on Susceptibility
to Antibiotics in Clinical Isolates of Escherichia coli
Producers of Extended-Spectrum Beta-Lactamases 645
A. Sorlózano, A. Salmerón, F. Martínez-Checa, E. Villegas,
J. D. Luna and J. Gutiérrez
Chapter 29 Antibiotic Resistance in Mariculture Environments of China 655
Jingyi Zhao and Hongyue Dang
viii Contents
Chapter 30 Antibiotic Resistance as a Method for Determining
Sources of Fecal Pollution in Water 665
Alexandria K. Graves and Charles Hagedorn
Chapter 31 Genetic Regulation, Physiology, Assessment and Inhibition
of Efflux Pumps Responsible for Multi-Drug Resistant
Phenotypes of Bacterial Pathogens 693
L. Amaral, S. Fanning, G. Spengler, L. Rodrigues, C. Iversen,
M. Martins, A. Martins, M. Viveiros and I. Couto
Chapter 32 Genetic and Phenotypic Characterization of Drug-Resistant
Mycobacterium Tuberculosis Isolates 713
Maysaa El Sayed Zaki
Chapter 33 Tracking Down a New Putative Drug Target for Osteoporosis:
Structure of an Essential Region of the Proton Translocation
Channel of H+-VO-ATPase 723
Afonso M. S. Duarte and Marcus A. Hemminga
Chapter 34 Antibiotic Resistance in Food-Associated Lactic Acid Bacteria 749
Giorgio Giraffa
Chapter 35 Current Status of Antibiotic Resistance in Lactic Acid Bacteria 757
Leon M. T. Dicks, Svetoslav D. Todorov
and Bernadette D. G. M. Franco
Chapter 36 Nanobiotics to Combat Bacterial Drug Resistance 801
Sampath C. Abeylath and Edward Turos
Chapter 37 Veterinary Antibiotics and their Possible Impact
on Resistant Bacteria in the Environment 841
Nicole Kemper
Index 869